ImmunoGen, Inc.

There’s a lot going on in the external operating environment for contract development and manufacturing organization (CDMOs) and firms like Syngene International Ltd. are navigating the turbulence r

Henlius Biotech’s Hetronifly (serplulimab) could soon be authorized for use in EU patients with extensive-stage small cell lung cancer (ES-SCLC) after the European Medicines Agency’s human medicine ad

Pfizer , Henlius Biotech and ImmunoGen could this week learn whether the European Medicines Agency will recommend in favor of pan-EU marketing authorization for their respective orphan drugs, marsta

Genmab A/S ‘s acquisition of antibody-drug conjugate (ADC) specialist ProfoundBio (Suzhou) Co., Ltd. earlier this year for $1.8bn in cash is looking like a shrewd bit of business following new data